| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Clorazepate | Ethyl Clorazepate | VE006730 | View CAS 5606-55-3 |
Clorazepate impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Clorazepate | Ethyl Clorazepate | VE006730 | View CAS 5606-55-3 |
[rfq_list]
| Catalogue No. | VE006730 |
| CAS No. | 5606-55-3 |
| Molecular Formula | C18H15ClN2O3 |
| Molecular Weight | 342.78 |
| Parent drug | Clorazepate |
| IUPAC Name | Ethyl 7-Chloro-2, 3-dihydro-2-oxo-5-phenyl-1H-1, 4-benzodiazepine-3-carboxylate |
| Synonyms | N/A |
| References | Europe PMC. “Europe PMC.” Europepmc.org, 2016, europepmc.org/article/med/2866771. ?De Wit, S., et al. “Efficacy and Safety of Trazodone versus Clorazepate in the Treatment of HIV-Positive Subjects with Adjustment Disorders: A Pilot Study.” Journal of International Medical Research, vol. 27, no. 5, Sept. 1999, pp. 223–32, https://doi.org/10.1177/030006059902700502. |
| Status | Not Available |
| ListName | Ethyl Clorazepate |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
